[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:gamma-delta-t-cell-lymphoma":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":15,"states":16},"Gamma delta T-cell lymphoma",1,[7],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT05996185","Study of Mogamulizumab With DA-EPOCH or CHOEP in Patients With Aggressive T-cell Lymphoma",[11],"Phase 2","RECRUITING","2026-08-26T02:16:52.995882Z","2026-05-05T02:43:28.341848Z",[],[]]